US25960P1093 - REIT

Taking everything into account, **DEI** scores **3** out of 10 in our fundamental rating. **DEI** was compared to 130 industry peers in the **Diversified REITs** industry. **DEI** has an average financial health and profitability rating. **DEI** is valued expensive and it does not seem to be growing.

In the past year **DEI** had a positive cash flow from operations.

Each year in the past 5 years **DEI** has been profitable.

In the past 5 years **DEI** always reported a positive cash flow from operatings.

Looking at the **Return On Equity**, with a value of **0.90%**, **DEI** is in line with its industry, outperforming **42.19%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **DEI** is in line with the industry average of **2.90%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.21% | ||

ROE | 0.9% | ||

ROIC | 1.5% |

ROA(3y)0.74%

ROA(5y)1.5%

ROE(3y)2.82%

ROE(5y)5.32%

ROIC(3y)1.72%

ROIC(5y)1.94%

In the last couple of years the **Operating Margin** of **DEI** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 17.99% | ||

PM (TTM) | 2.07% | ||

GM | 64.93% |

OM growth 3Y-2.09%

OM growth 5Y-3.9%

PM growth 3Y-36.96%

PM growth 5Y-3.46%

GM growth 3Y-0.87%

GM growth 5Y-0.52%

The number of shares outstanding for **DEI** has been increased compared to 5 years ago.

Based on the Altman-Z score of **0.21**, we must say that **DEI** is in the distress zone and has some risk of bankruptcy.

The **Altman-Z score** of **DEI** (**0.21**) is worse than **71.88%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.37 | ||

Debt/FCF | 27.79 | ||

Altman-Z | 0.21 |

ROIC/WACC0.25

WACC6%

With an excellent **Quick ratio** value of **3.06**, **DEI** belongs to the best of the industry, outperforming **90.63%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.06 | ||

Quick Ratio | 3.06 |

The **Earnings Per Share** has been decreasing by **-0.71%** on average over the past years.

Measured over the past years, **DEI** shows a small growth in **Revenue**. The Revenue has been growing by **4.12%** on average per year.

EPS 1Y (TTM)-76.92%

EPS 3Y-35.82%

EPS 5Y-0.71%

EPS growth Q2Q-161.54%

Revenue 1Y (TTM)3.78%

Revenue growth 3Y1.99%

Revenue growth 5Y4.12%

Revenue growth Q2Q0.69%

The **Earnings Per Share** is expected to decrease by **-41.59%** on average over the next years. This is quite bad

The **Revenue** is expected to decrease by **-3.05%** on average over the next years.

EPS Next Y-119.1%

EPS Next 2Y-62.34%

EPS Next 3Y-41.59%

EPS Next 5YN/A

Revenue Next Year0.89%

Revenue Next 2Y-0.48%

Revenue Next 3Y-3.05%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

Based on the **Price/Earnings** ratio of **102.50**, the valuation of **DEI** can be described as expensive.

Compared to the rest of the industry, the **Price/Earnings** ratio of **DEI** is on the same level as its industry peers.

When comparing the **Price/Earnings** ratio of **DEI** to the average of the S&P500 Index (**24.54**), we can say **DEI** is valued expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 102.5 | ||

Fwd PE | N/A |

Based on the **Enterprise Value to EBITDA** ratio, **DEI** is valued a bit cheaper than the industry average as 72.66% of the companies are valued more expensively.

90.63% of the companies in the same industry are more expensive than **DEI**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 10.28 | ||

EV/EBITDA | 11.54 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-62.34%

EPS Next 3Y-41.59%

With a **Yearly Dividend Yield** of **6.67%**, **DEI** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.63**, **DEI** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.67% |

The dividend of **DEI** has a limited annual growth rate of **4.26%**.

Dividend Growth(5Y)4.26%

Div Incr Years12

Div Non Decr Years13

The **Dividend Rate** of **DEI** has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.

DP702.95%

EPS Next 2Y-62.34%

EPS Next 3Y-41.59%

**DOUGLAS EMMETT INC**

NYSE:DEI (11/29/2023, 7:04:00 PM)

After market: 12.3 0 (0%)**12.3**

**+0.25 (+2.07%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)10-31 2023-10-31/amc

Earnings (Next)02-05 2024-02-05/amc

Inst Owners113.66%

Inst Owner Change-0.47%

Ins Owners4.5%

Ins Owner Change0.13%

Market Cap2.05B

Analysts54.29

Price Target13.68 (11.22%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.67% |

Dividend Growth(5Y)4.26%

DP702.95%

Div Incr Years12

Div Non Decr Years13

Ex-Date09-28 2023-09-28 (0.19)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-68.36%

Min EPS beat(2)-142.43%

Max EPS beat(2)5.7%

EPS beat(4)2

Avg EPS beat(4)-33.55%

Min EPS beat(4)-142.43%

Max EPS beat(4)6.63%

Revenue beat(2)1

Avg Revenue beat(2)-0.08%

Min Revenue beat(2)-1.23%

Max Revenue beat(2)1.06%

Revenue beat(4)1

Avg Revenue beat(4)-0.95%

Min Revenue beat(4)-2.07%

Max Revenue beat(4)1.06%

PT rev (1m)-1.67%

PT rev (3m)-1.04%

EPS NQ rev (1m)-9.76%

EPS NQ rev (3m)-427.27%

EPS NY rev (1m)0%

EPS NY rev (3m)-146.22%

Revenue NQ rev (1m)0.1%

Revenue NQ rev (3m)0.39%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.1%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 102.5 | ||

Fwd PE | N/A | ||

P/S | 2.02 | ||

P/FCF | 10.28 | ||

P/OCF | 4.58 | ||

P/B | 0.88 | ||

P/tB | 0.88 | ||

EV/EBITDA | 11.54 |

EPS(TTM)0.12

EY0.98%

EPS(NY)-0.35

Fwd EYN/A

FCF(TTM)1.2

FCFY9.72%

OCF(TTM)2.68

OCFY21.82%

SpS6.09

BVpS14.02

TBVpS13.99

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.21% | ||

ROE | 0.9% | ||

ROCE | 1.9% | ||

ROIC | 1.5% | ||

ROICexc | 1.59% | ||

ROICexgc | 1.63% | ||

OM | 17.99% | ||

PM (TTM) | 2.07% | ||

GM | 64.93% | ||

FCFM | 19.64% |

ROA(3y)0.74%

ROA(5y)1.5%

ROE(3y)2.82%

ROE(5y)5.32%

ROIC(3y)1.72%

ROIC(5y)1.94%

ROICexc(3y)1.77%

ROICexc(5y)1.99%

ROICexgc(3y)1.79%

ROICexgc(5y)2.01%

ROCE(3y)2.17%

ROCE(5y)2.46%

ROICexcg growth 3Y-0.28%

ROICexcg growth 5Y-2.6%

ROICexc growth 3Y-1.17%

ROICexc growth 5Y-2.99%

OM growth 3Y-2.09%

OM growth 5Y-3.9%

PM growth 3Y-36.96%

PM growth 5Y-3.46%

GM growth 3Y-0.87%

GM growth 5Y-0.52%

F-Score6

Asset Turnover0.1

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.37 | ||

Debt/FCF | 27.79 | ||

Debt/EBITDA | 9.05 | ||

Cap/Depr | 57.68% | ||

Cap/Sales | 24.43% | ||

Interest Coverage | 1.02 | ||

Cash Conversion | 73.04% | ||

Profit Quality | 950.83% | ||

Current Ratio | 3.06 | ||

Quick Ratio | 3.06 | ||

Altman-Z | 0.21 |

F-Score6

WACC6%

ROIC/WACC0.25

Cap/Depr(3y)102.91%

Cap/Depr(5y)111.49%

Cap/Sales(3y)40.84%

Cap/Sales(5y)43.02%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y (TTM)-76.92%

EPS 3Y-35.82%

EPS 5Y-0.71%

EPS growth Q2Q-161.54%

EPS Next Y-119.1%

EPS Next 2Y-62.34%

EPS Next 3Y-41.59%

EPS Next 5YN/A

Revenue 1Y (TTM)3.78%

Revenue growth 3Y1.99%

Revenue growth 5Y4.12%

Revenue growth Q2Q0.69%

Revenue Next Year0.89%

Revenue Next 2Y-0.48%

Revenue Next 3Y-3.05%

Revenue Next 5YN/A

EBIT growth 1Y-21.95%

EBIT growth 3Y-0.15%

EBIT growth 5Y0.05%

EBIT Next Year152.07%

EBIT Next 3Y35.75%

EBIT Next 5YN/A

FCF growth 1Y188.96%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y11%

OCF growth 3Y1.9%

OCF growth 5Y4.29%